Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary Effects of Bronchial Segmental Endotoxin Instillation in Humans
NCT02392442Phase 2Enrolling by invitation
- Sponsor
- National Institutes of Health
- Start
- Jun 2015
- Primary completion
- Jun 2027
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of lipopolysaccharide endotoxin, sponsored by National Institutes of Health. Started Jun 2015; status: enrolling by invitation.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NCT02392442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02392442.